India's GMO gridlock is not a scientific disagreement — it is a governance failure
Farmers already have awareness, interest, and desire — the formal adoption pathway is the only thing broken
Unapproved GM seeds are spreading through shadow markets, which proves demand exists
The state has simultaneously blocked legal access and abandoned enforcement
Farmers are left bearing all the risk of an unregulated market — that is the core ethical problem
Separating facts from assumptions
The claim that GM crops harm human health is not supported by WHO or three decades of global evidence
Environmental risks from gene flow are real but context-dependent — they vary by crop and ecosystem
Corporate control of seeds is not an inherent feature of GM technology; it depends on IP and competition policy
Bt cotton showed real early gains — the subsequent distress came from pest resistance and pricing, not the technology itself
Conflating these distinct questions has allowed misinformation to capture the policy space
Where the real ethical tensions lie
Farmer autonomy vs. regulatory paternalism — farmers are already choosing GM seeds, just illegally
Food security vs. environmental precaution — India spends ₹1.6 trillion annually on edible oil imports, and that cost falls on real households
Scientific approval vs. democratic legitimacy — GEAC cleared Bt brinjal, a minister overrode it, and no transparent framework exists to navigate that tension
Each dilemma points to a different kind of governance failure
They cannot be resolved by the same policy instrument
Why good policy has not happened yet
Regulators face asymmetric incentives — approving a crop that later generates controversy brings political cost, delaying indefinitely brings none
Organised civil society groups opposing GM are vocal and concentrated; farmers who would benefit are dispersed and politically weak
The Bt brinjal moratorium in 2010 was not a scientific decision — it was a political one
The Supreme Court's split verdict on GM mustard reflects the same unresolved tension
Until the incentive structure facing regulators changes, expect more gridlock regardless of what the science says
What this means for governance priorities
Farmers need protection from shadow market risks — this is a government failure rooted in the enforcement gap
Seed market concentration must be addressed separately from biosafety — bundling them has paralysed both debates
Regulatory credibility needs to be rebuilt through consistent, transparent process — not faster approvals alone
Policy cannot eliminate residual scientific uncertainty or override deeply held cultural objections
But it can stop making small farmers bear the cost of decisions made in New Delhi